Harbin Pharmaceutical Group Co Ltd (600664 SHG) stock market data APIs

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, antiviral and anti-infective, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, and antibiotics. It also provides calcium iron zinc oral solutions, zinc gluconate oral solutions, compound calcium gluconate oral solutions, Shuanghuanglian oral solutions, amoxicillin capsules, human erythropoietin injections, iron and vitamin B12 oral solutions, calcium, iron, and zinc oral solutions, ceftriaxone sodium injections, Qufenggutong gel ointment, GNC Vitapak nutritional pack, lacidipine tablets, GNC fish oil capsules, coenzyme Q10 and panthenol soft capsules, GNC children's liquid calcium magnesium zinc, penicillin sodium, acetaminophen and chlorpheniramine maleate granules, glucosamine chondroitin calcium tablets, ceftriaxone sodium for injection, GNC milk thistle extract tablets and capsules, and compound sulfamethoxazole oral tablets. The company is also involved in culture, science and technology, pharmaceutical commercial and industry, property, and investment activities. Harbin Pharmaceutical Group Co., Ltd. was founded in 1991 and is based in Harbin, China.